Zenk v. Paul Revere Life Insurance

171 F. Supp. 2d 929, 27 Employee Benefits Cas. (BNA) 1470, 2000 U.S. Dist. LEXIS 21600, 2000 WL 33644481
CourtDistrict Court, D. Minnesota
DecidedNovember 14, 2000
DocketCiv.00-2082(DSD/JMM)
StatusPublished
Cited by1 cases

This text of 171 F. Supp. 2d 929 (Zenk v. Paul Revere Life Insurance) is published on Counsel Stack Legal Research, covering District Court, D. Minnesota primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Zenk v. Paul Revere Life Insurance, 171 F. Supp. 2d 929, 27 Employee Benefits Cas. (BNA) 1470, 2000 U.S. Dist. LEXIS 21600, 2000 WL 33644481 (mnd 2000).

Opinion

ORDER

DOTY, District Judge.

This matter is before the court on defendant’s motion for summary judgment. Based on a review of the file, record and the proceedings herein, the court grants defendant’s motion.

BACKGROUND

The facts in this case are undisputed. Plaintiff is a physician who received his M.D. from the University of Minnesota in 1983. From 1986 through 1995, plaintiff was employed as an internist with Hutchinson Area Health Care and the Hutchinson Medical Center. On December 17, 1990, defendant issued an insurance policy to plaintiff (the “policy”). 1 The policy provided coverage if plaintiff incurred “Total Disability” and was unable to perform the “important duties” of his occupation and was under the regular and personal care of a physician. 2

In 1992, plaintiff underwent neck surgery. After surgery, plaintiff experienced discomfort and began self-prescribing Vi-codin and other narcotic painkiller medications. (Dep. John L. Zenk at 11-13.) Plaintiff continued to self-prescribe painkiller medications and became addicted to these drugs. (Id. at 19-20, 23.)

On September 30, 1998, plaintiff was confronted in his office by members of the United States Drug Enforcement Agency (“DEA”). (Id. at 27.) 3 He immediately discontinued the use of narcotic medications after that confrontation and asserts that he has not used narcotics since that date. (Id. at 22-23.) As a result of the DEA investigation, plaintiffs use of narcotic medications was reported to the Minnesota Board of Medical Practice (the “board”). (Id. at 27.) The board appointed a complaint review committee (the “committee”) to investigate plaintiffs use *931 of narcotic medications. Plaintiff appeared before the committee on October 30, 1998. The committee recommended that plaintiff undergo a comprehensive evaluation through the Professional Assessment Program (“PAP”) at Abbott-Northwestern Hospital in Minneapolis. Plaintiff was admitted to PAP on January 18, 1999, and was discharged on January 21,1999. (Id. at 70.)

On March 22,1999, the assessment team of PAP issued a report containing its diagnosis and assessment of plaintiff. The primary diagnosis was that plaintiff had an “opiode dependency,” and the assessment concluded that:

Based on his current psychological and addiction assessment, Dr. Zenk should be safe to practice after he completes the intensive residential phase of treatment and demonstrates that he has initiated a solid recovery program. There was no evidence of impairment in practice.

(Id., Ex. 2.)

The assessment team recommended that plaintiff enroll in an out-state intensive residential treatment program for chemical dependency. (Id.)

In conjunction with the assessment team’s report, the state licensing board committee prepared a stipulation and order for plaintiffs signature. ■ (Id., Ex. 7.) The proposed stipulation and order contained the assessment team’s diagnosis and its conclusion that plaintiff “should be safe to practice [medicine] after he completes intensive residential treatment and demonstrates that he has initiated a solid recovery program.” (Id. at 70; Ex. 7 at 3.) The proposed stipulation and order also contained a number of conditions and restrictions that were to be placed upon plaintiffs license to practice medicine in light of his abuse of narcotic medication. 4

Because plaintiff considered some of the conditions to be unreasonable restrictions on his ability to practice medicine, he refused to execute the proposed stipulation and order. 5 (Id. at 70-71.) In conjunction with his refusal to sign the proposed stipulation and order, sometime between May and July 1999, plaintiff decided to quit practicing medicine. (Id. at 51-52.) On July 18, 1999, plaintiff sent a letter to Charles Becker, the insurance agent who had sold him the policy, notifying the insurer of his decision to quit the practice of medicine. (Id., Ex. 3.)

Plaintiff continued to work full-time in his medical practice from the time he discontinued using narcotics in October 1998 through the date he terminated his employment on August 31, 1999. (Zenk Dep. *932 at 44.) During this time period of nearly eleven months, the parties do not disagree that plaintiffs job responsibilities and workload were essentially unchanged, despite the board’s investigation and plaintiffs self-stated fear of relapse. (Id. at 44). Plaintiffs wife, colleagues and employer also agree that plaintiffs job responsibilities and workload were essentially unchanged during this period of time. (Connie Zenk Dep. at 15-16; Sandler Dep. at 9; Stein Dep. at 17-18, 37.) 6

Both during the board’s investigation and after he decided to surrender his license, plaintiff declined to pursue any chemical dependency treatment or counseling. (Zenk Dep. at 66, 68, 131.) Plaintiff testified that he “felt that [he] didn’t need it.” (Id. at 66.) Plaintiff also testified that regarding his decision to surrender his medical license, “the whole drug issue really didn’t have a whole lot to do with it” and “I [was] ready to back away from the practice of medicine and do something else for a while.” (Zenk Dep. II at 169-170.) 7

Plaintiff filed the present claim for disability benefits with Paul .Revere Insurance on or about September 28, 1999, asserting that he was disabled by virtue of his chemical dependency on and after September 1, 1999. In November 1999, plaintiff advised a representative of defendant that he would be working but for the loss of his medical license. (Lemoine Aff., Ex. B.) 8

In a letter dated December 8, 1999, defendant denied plaintiffs claim for disability benefits. (Id., Ex. C.) Defendant asserted that plaintiff had failed to satisfy the definition of disability under the policy. (Id.) Defendant further reasoned that the limitations and restrictions on plaintiffs ability to practice medicine were caused by factors other than injury or sickness. (Id.)

Defendant now moves for summary judgment asserting that as a matter of law *933 plaintiff is not entitled to disability benefits because he is not disabled within the meaning of the policy. In particular, defendant asserts that plaintiff cannot establish that his inability to practice medicine is the result of a disability but rather is the result of his own decision to voluntarily relinquish his medical license.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Massachusetts Mutual Life Insurance Co. v. Jefferson
104 S.W.3d 13 (Court of Appeals of Tennessee, 2002)

Cite This Page — Counsel Stack

Bluebook (online)
171 F. Supp. 2d 929, 27 Employee Benefits Cas. (BNA) 1470, 2000 U.S. Dist. LEXIS 21600, 2000 WL 33644481, Counsel Stack Legal Research, https://law.counselstack.com/opinion/zenk-v-paul-revere-life-insurance-mnd-2000.